Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria

Gabriele Campanella(Mount Sinai Health System), Andrew D. Luster(Massachusetts General Hospital), Andrew M. Tager, Tabitha A. Abrazinski(Harvard University), Richard A. Colvin(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Seddon Y. Thomas(Harvard University), Joseph K. El Khoury(Harvard University), Lindsay A. Manice(Harvard University)
Proceedings of the National Academy of Sciences
March 17, 2008
Cited by 289


Related Papers